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Experimental Procedures
Strains and Culture conditions
Aspergillus fumigatus strains used in this study are listed in Table S1 . Strains were maintained on Czapek-Dox agar or glucose minimal agar (GMM) 1 
Chemicals and chemical analysis
Labeled of sample was injected. A flow of 1.5 mL/min of helium was used as carrier gas. Electronic impact was recorded at 70 eV. 1 H, 13 C and 2D NMR spectra were obtained on Bruker AV500
spectrometer with a 5 mm dual cryoprobe at the UCLA Molecular Instrumentation Center.
S3
General Molecular Biology Experiments
General molecular cloning techniques were as described elsewhere. 2 Generation of Aspergillus fumigatus AFU8G_0370 andAFU8G_0520 deletion mutants
S4
The DNA cassette used for gene replacement was generated by fusion PCR, using A. 8 (a gift from Dr. Cramer) was performed as described previously. 7 The gene replacement resulted in a partial deletion of Afu8g00370, from the translation start site (+1) to +2010 bp. The partial deletion was confirmed by PCR (data not shown) and Southern blot ( Figure S1 ). The resulting transformant was designated TSD49.1.
The gene Afu8g00520 (ortholog of ubiA encoding a putative prenyltransferase) was deleted following a similar strategy. Approximately, 1.4kb fragments corresponding to the 5'UTR and 3'UTR of Afu8g00520 were amplified from A. fumigatus genomic DNA using primer pairs afu8g520-p1 and afu8g520-p2, and afu8g520-p3 and afu8g520-p4, respectively. Next, the A.
parasiticus pyrG gene was amplified from plasmid pSD38.1 using primers afu8g520-p5 and afu8g520-p6. All three fragments were fused by PCR using the nested primers afu8g520-nestF and afu8g520-nestR. A. fumigatus akuB ku80 was also used as host strain for fungal transformation using this fusion PCR product. The gene replacement resulted in a complete deletion of Afu8g00520 coding region. The deletion was also confirmed by PCR (data not shown) and Southern blot ( Figure S6 ). Several transformants were obtained. The resulting transformant was designated TSD50.1.
S5
An isogenic control strain was also obtained by transforming A. fumigatus akuB ku8 with a wild-type copy of the A. fumigatus pyrG gene. The DNA fragment containing pyrG used for this transformation was PCR amplified from p1439 (Stinnett et al., 2007) with primers CoLinkerF_641 and ColinkerR_642. The resulting transformant was designated TSD51.1.
Construction of plasmid for fma-PKS expression in S. cerevisiae
The fma-PKS expression plasmid, pHCfmaPKS, was constructed using in vivo yeast recombination cloning. The complete fma-PKS cDNA was constructed by three overlapping fragments (Table S4 ). The middle largest exon region (4479 bp) that was predicted to not contain any intron was amplified from A. fumigatus gDNA using primer pair FG370-P2-F with FG370-P2-R (fragment designated as FG370-P2). The 3′ and 5′ end regions were predicted to contain introns and were thus amplified from cDNA. RNA was extracted from a four-day old culture in CYB medium using the RiboPure Yeast Kit (Ambion) following the manufacturer's instructions and residual gDNA in the total RNA was digested with DNase (2 U/μL) (Invitrogen)
at 37 o C for four hours. The 3′ and 5′ fma-PKS cDNA was synthesized using ImProm-II TM Reverse Transcription System with the reverse primers FG370-P1-R and FG370-P3-R, respectively (Table S4 ). The cDNA was used as template for PCR. The 3′ and 5′ intron-free cDNA fragments were amplified using primer pairs FG370-P1-F/FG370-P1-R-T ADH2 and P ADH2-FG370-P3-F/FG370-P3-R3 (designated as P ADH2 -FG370-P3 and FG370-P1-T ADH2 respectively).
For in vivo yeast recombination, the three overlapping fragments, P ADH2 -FG370-P3, FG370-P2
and FG370-P1-T ADH2 , were combined with a PmlI/NdeI-linearized YEplac195-derived 2μ expression plasmid (containing URA3 marker) flanking with P ADH2 promoter and T ADH2
terminator (also encode a 6×His-tag and stop codon); 9 co-transfomation of S. cerevisiae BJ5464- 
Construction of plasmid for fma-AT expression in S. cerevisiae
An intron-free fma-AT was constructed from cDNA which was synthesized with the reverse primer pHis8-FG380-R using ImProm-II TM Reverse Transcription System. The cDNA was used
S6
as template for PCR and amplified by using primer pair pHis8-FG380-F and pHis8-FG380-R, which contained EcoRI and NotI restriction sites, respectively. To introduce 8×His-tag to the Nterminal of fma-AT, the PCR product was digested with EcoRI and NotI and ligated into the EcoRI/NotI-digested pHis8 expression vector, 10 to yield plasmid pHCHis8fmaAT. This plasmid was used as template for PCR using primer pair ADH2p-380-F with ADH2t-380-R. The resulting PCR product and an NdeI/HindIII-linearized YEplac112-derived 2 μ expression plasmid (containing TRP1 marker) were combined; co-transformation of S. cerevisiae BJ5464- Purified protein was concentrated and buffer was exchanged into Buffer B (50 mM Tris-HCl, 2 mM EDTA, 100 mM NaCl, pH 8.0) using an Amicon Ultra-15 Centrifugal Filter Unit and stored in 10% glycerol. The purified fma-PKS and fma-AT were analyzed by SDS-PAGE ( Figure S2A) and their concentration were calculated to be 3.5 mg/L and 18.0 mg/L, respectively, using the Bradford assay with BSA as a standard.
In vitro assays of fma-PKS and fma-AT
For in vitro synthesis of dodecapentaenoic acid 4, 10 µM fma-PKS and 10 µM fma-AT were incubated with 2 mM malonyl-CoA, 1 mM NADPH in 100 mM PBS, pH 7.4 in a total 100 µL S7 reaction. The reaction was incubated at room temperature overnight and extracted with 100 µL ethyl acetate with 1% acetic acid twice. The organic phase was dried and dissolved in 20 µL
MeOH for analysis on LC-MS. For in vitro synthesis of 5-dodecapentaenoyl fumagillol 5, 1 mM fumagillol 2 was supplemented to the same reaction condition above in 100 µL volume following the same protocols. For in vitro synthesis of 13 C-labeled dodecapentaenoic acid, 10
µM fma-PKS and 10 µM fma-AT were incubated with 100 mM [2-
13 C]-malonate (unlabeled malonate used for control reaction) and a malonyl-CoA regeneration system (10 mM Mg 2 Cl 2 , 25 mM ATP, 10 mM CoA, 25 μM MatB, 1 mM NADPH) in 100 mM PBS buffer, pH 7.4 in total 100 µL volume. The reaction was incubated at room temperature for overnight, extracted and analyzed by LCMS as above ( Figure S3 ).
Cloning, expression, and preparation of fma-TC-containing microsomes for in vitro assay
The complete fma-PKS cDNA was constructed by two overlapping fragments using yeast in vivo recombination cloning (Table S4 ). The 3′ and 5′ end regions were predicted to contain introns and were thus amplified from cDNA. cDNA was synthesized using ImProm-II TM Reverse
Transcription System with the anchored oligo-dT reverse primer. The cDNA was used as template for PCR. The 3' and 5' intron-free cDNA fragments were amplified using primer pairs P ADH2 -FG520-P1-F/FG520-P1-R (P ADH2 -FG520-P1 fragment) and FG520-P2-F/FG520-P2-R-5-T ADH2 (FG520-P2-T ADH2 fragment). For in vivo recombination, S. cerevisiae BJ5464-NpgA were co-transformed with three overlapping fragments, P ADH2 -FG520-P1, FG520-P2-T ADH2 and a SwaI/NdeI-linearized YEplac195-derived 2μ expression plasmid (containing URA3 marker) flanking with P ADH2 promoter and T ADH2 terminator (no His tag) to yield the expression plasmid pHCfmaTC.
For expression of fma-TC, the cells were grown in YPD medium supplemented with 1% dextrose at 28 o C with shaking for 48 hours. The microsomes were prepared according to the protocol described previously. 11 Briefly, the cells were harvested by centrifugation (3,750 rpm at The reactions were stopped at 15 min, 30 min, 1 hours and 2 hours by adding 100 μL hexanes and extracted twice, respectively. The organic phase was dried and re-dissolved in 5 µL DMF for analysis by GC-FID. The concentration of β-trans-bergamotene produced was measured by the peak area compared to the standard curve. The conversion rate of 3 was measured to be 4.4 μMmin -1 in the presence 10 mg/mL microsomes. The amount of protein in 10 mg/mL microsomes was calculated to be 250 μg/mL based on a modified Bradford assay against a BSA standard curve (protein samples were pre-denatured in 0.1 M NaOH).
Purification and characterization of compound 3
S. cerevisiae strain BJ5464-NpgA harboring pHCfmaTC plasmid was inoculated to 4 mL 
anchored oligo-dT reverse primer TTTTTTTTTTTTTTTTTTTTTVN Table S3 . Deduced functions of genes within the fma cluster a The fma gene cluster is located adjacent to the pseurotin A gene cluster (the locus tag of PKS-NRPS gene psoA is AFUA_8G00540). b The CDS annotation for the two genes in asterisks (*) on the GenBank database is incorrect (see Table S4 for the correct gene structure and Supplementary methods a The complete coding sequence of fma-PKS gene is constructed by yeast recombination from two cDNA fragments amplified from total RNA by RT-PCR using 370-P1-F/P1-R and 370-P3-F/P3-R primers, and an intron-less fragment amplified from genomic DNA of A. fumigatus using 370-P2-F/P2-R. Sequencing of the cloned 370-P1-F/P1-R and 370-P3-F/P3-R cDNA fragments revealed the correct exon regions (*misannotated introns). b The complete coding sequence of fma-TC gene is constructed by yeast recombination from two cDNA fragments using FG520-P1-F/P1-R and FG520-P2-F/P2-R-5 primers amplified from total RNA by RT-PCR. The exon regions of 5′ fragment is determined by sequencing of the cloned FG520-P1-F/P1-R cDNA fragment, while sequencing of the 3′ cDNA fragment amplified with FG520-P2-F and FG520-P2-R-2 (located at 3′ untranslated region) revealed the correct exon regions and the stop codon. NOTE For more details for cloning of the two genes for expression in S. cerevisiae, see Supplementary Methods. 
A B
Homology model based on template c3ts7B: Chain B, farnesyl diphosphate synthase from Methylococcus capsulatus.
188 residues (65% of Af520 (fma-TC) 289 residues protein sequence, aligned region shown above) have been modeled with 92.4% confidence by the single highest scoring template. hcl-20121202-AF520, 13C spectrum, AF520-cel-acetone-Hex-Silica-Fr.1, in CDCl3, AV500-cryo, 2012/12/02 Figure S9 . HSQC135 spectrum of 3 (CDCl 3 , 500 MHz). 
